Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency
NCT02045017
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
81
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
Pomalidomide and Dexamethasone
Sponsor
Celgene